Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells.

Manoli S, Coppola S, Duranti C, Lulli M, Magni L, Kuppalu N, Nielsen N, Schmidt T, Schwab A, Becchetti A, Arcangeli A.

Cancers (Basel). 2019 Jan 23;11(2). pii: E135. doi: 10.3390/cancers11020135.

2.

Abnormalities in functional connectivity in borderline personality disorder: Correlations with metacognition and emotion dysregulation.

Quattrini G, Pini L, Pievani M, Magni LR, Lanfredi M, Ferrari C, Boccardi M, Bignotti S, Magnaldi S, Cobelli M, Rillosi L, Beneduce R, Rossi G, Frisoni GB, Rossi R.

Psychiatry Res Neuroimaging. 2019 Jan 30;283:118-124. doi: 10.1016/j.pscychresns.2018.12.010. Epub 2018 Dec 20.

PMID:
30591402
3.

Multiple digit melanonychia: Examine the scalp.

Lambertini M, Filippi F, Traniello Gradassi A, Magni L, Dika E.

J Am Acad Dermatol. 2018 May;78(5):e97-e98. doi: 10.1016/j.jaad.2017.11.051. Epub 2017 Dec 5. No abstract available.

PMID:
29208417
4.

Prevalence and severity of childhood adversity in adolescents with BPD, psychiatrically healthy adolescents, and adults with BPD.

Temes CM, Magni LR, Fitzmaurice GM, Aguirre BA, Goodman M, Zanarini MC.

Personal Ment Health. 2017 Aug;11(3):171-178. doi: 10.1002/pmh.1387.

PMID:
28786232
5.

Psychosocial functioning in adolescents with and without borderline personality disorder.

Kramer U, Temes CM, Magni LR, Fitzmaurice GM, Aguirre BA, Goodman M, Zanarini MC.

Personal Ment Health. 2017 Aug;11(3):164-170. doi: 10.1002/pmh.1377. Epub 2017 Jun 8.

PMID:
28597585
6.

Prevalence rates of childhood protective factors in adolescents with BPD, psychiatrically healthy adolescents and adults with BPD.

Borkum DB, Temes CM, Magni LR, Fitzmaurice GM, Aguirre BA, Goodman M, Zanarini MC.

Personal Ment Health. 2017 Aug;11(3):189-194. doi: 10.1002/pmh.1380. Epub 2017 May 28.

7.

Prevalence rates of borderline symptoms reported by adolescent inpatients with BPD, psychiatrically healthy adolescents and adult inpatients with BPD.

Zanarini MC, Temes CM, Magni LR, Fitzmaurice GM, Aguirre BA, Goodman M.

Personal Ment Health. 2017 Aug;11(3):150-156. doi: 10.1002/pmh.1378. Epub 2017 May 28.

PMID:
28556496
8.

Parental evaluation of a telemonitoring service for children with Type 1 Diabetes.

Losiouk E, Lanzola G, Del Favero S, Boscari F, Messori M, Rabbone I, Bonfanti R, Sabbion A, Iafusco D, Schiaffini R, Visentin R, Galasso S, Di Palma F, Chernavvsky D, Magni L, Cobelli C, Bruttomesso D, Quaglini S.

J Telemed Telecare. 2018 Apr;24(3):230-237. doi: 10.1177/1357633X17695172. Epub 2017 Mar 26.

PMID:
28345384
9.

Superwellness Program: a cognitive-behavioral therapy-based group intervention to reduce weight gain in patients treated with antipsychotic drugs.

Magni LR, Ferrari C, Rossi G, Staffieri E, Uberti A, Lamonaca D, Boggian I, Merlin S, Primerano G, Mombrini A, Poli R, Saviotti FM, Caldera MT, Zanotti L, Rossi R.

Braz J Psychiatry. 2017 Jul-Sep;39(3):244-251. doi: 10.1590/1516-4446-2016-1993. Epub 2017 Mar 13.

10.

Increased oxidative stress alters nucleosides metabolite levels in sickle cell anemia.

Castilhos LG, de Oliveira JS, Adefegha SA, Magni LP, Doleski PH, Abdalla FH, de Andrade CM, Leal DBR.

Redox Rep. 2017 Nov;22(6):451-459. doi: 10.1080/13510002.2017.1288973. Epub 2017 Feb 16.

PMID:
28209096
11.

Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results.

Toffanin C, Visentin R, Messori M, Palma FD, Magni L, Cobelli C.

IEEE Trans Biomed Eng. 2018 Mar;65(3):479-488. doi: 10.1109/TBME.2017.2652062. Epub 2017 Jan 11.

PMID:
28092515
12.

Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study.

Lanfredi M, Deste G, Ferrari C, Barlati S, Magni LR, Rossi R, de Peri L, Bonomi M, Rossi G, Vita A.

Cogn Neuropsychiatry. 2017 Jan;22(1):53-68. doi: 10.1080/13546805.2016.1260537. Epub 2016 Dec 6.

PMID:
27921860
13.

Remote Blood Glucose Monitoring in mHealth Scenarios: A Review.

Lanzola G, Losiouk E, Del Favero S, Facchinetti A, Galderisi A, Quaglini S, Magni L, Cobelli C.

Sensors (Basel). 2016 Nov 24;16(12). pii: E1983. Review.

14.

Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a Diabetes Camp Setting.

Troncone A, Bonfanti R, Iafusco D, Rabbone I, Sabbion A, Schiaffini R, Galderisi A, Marigliano M, Rapini N, Rigamonti A, Tinti D, Vallone V, Zanfardino A, Boscari F, Del Favero S, Galasso S, Lanzola G, Messori M, Di Palma F, Visentin R, Calore R, Leal Y, Magni L, Losiouk E, Chernavvsky D, Quaglini S, Cobelli C, Bruttomesso D.

Diabetes Care. 2016 Dec;39(12):2158-2164. Epub 2016 Oct 4.

PMID:
27852685
15.

Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: Involvement of acetylcholinesterase and cell death.

de Oliveira JS, Abdalla FH, Dornelles GL, Adefegha SA, Palma TV, Signor C, da Silva Bernardi J, Baldissarelli J, Lenz LS, Magni LP, Rubin MA, Pillat MM, de Andrade CM.

Neurotoxicology. 2016 Dec;57:241-250. doi: 10.1016/j.neuro.2016.10.008. Epub 2016 Oct 13.

PMID:
27746125
16.

Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial.

Kropff J, DeJong J, Del Favero S, Place J, Messori M, Coestier B, Farret A, Boscari F, Galasso S, Avogaro A, Bruttomesso D, Cobelli C, Renard E, Magni L, DeVries JH; AP@home consortium.

Diabet Med. 2017 Feb;34(2):262-271. doi: 10.1111/dme.13268. Epub 2016 Oct 28.

17.

Model individualization for artificial pancreas.

Messori M, Toffanin C, Del Favero S, De Nicolao G, Cobelli C, Magni L.

Comput Methods Programs Biomed. 2016 Jul 5. pii: S0169-2607(15)30443-0. doi: 10.1016/j.cmpb.2016.06.006. [Epub ahead of print]

PMID:
27424482
18.

Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe.

Del Favero S, Boscari F, Messori M, Rabbone I, Bonfanti R, Sabbion A, Iafusco D, Schiaffini R, Visentin R, Calore R, Moncada YL, Galasso S, Galderisi A, Vallone V, Di Palma F, Losiouk E, Lanzola G, Tinti D, Rigamonti A, Marigliano M, Zanfardino A, Rapini N, Avogaro A, Chernavvsky D, Magni L, Cobelli C, Bruttomesso D.

Diabetes Care. 2016 Jul;39(7):1180-5. doi: 10.2337/dc15-2815. Epub 2016 May 10.

PMID:
27208335
19.

Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.

Renard E, Farret A, Kropff J, Bruttomesso D, Messori M, Place J, Visentin R, Calore R, Toffanin C, Di Palma F, Lanzola G, Magni P, Boscari F, Galasso S, Avogaro A, Keith-Hynes P, Kovatchev B, Del Favero S, Cobelli C, Magni L, DeVries JH; AP@home Consortium.

Diabetes Care. 2016 Jul;39(7):1151-60. doi: 10.2337/dc16-0008. Epub 2016 May 5.

PMID:
27208331
20.

Down-regulation of adenosine A1 and A2A receptors in peripheral cells from idiopathic normal-pressure hydrocephalus patients.

Casati M, Arosio B, Gussago C, Ferri E, Magni L, Assolari L, Scortichini V, Nani C, Rossi PD, Mari D.

J Neurol Sci. 2016 Feb 15;361:196-9. doi: 10.1016/j.jns.2015.12.040. Epub 2015 Dec 28.

PMID:
26810542
21.

2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.

Kropff J, Del Favero S, Place J, Toffanin C, Visentin R, Monaro M, Messori M, Di Palma F, Lanzola G, Farret A, Boscari F, Galasso S, Magni P, Avogaro A, Keith-Hynes P, Kovatchev BP, Bruttomesso D, Cobelli C, DeVries JH, Renard E, Magni L; AP@home consortium.

Lancet Diabetes Endocrinol. 2015 Dec;3(12):939-47. doi: 10.1016/S2213-8587(15)00335-6. Epub 2015 Sep 30.

PMID:
26432775
22.

Myocardial bridge as a trigger of Kounis syndrome.

Venturini E, Marabotti C, Magni L, Testa R, Kounis NG.

Int J Cardiol. 2016 Jan 1;202:87-9. doi: 10.1016/j.ijcard.2015.08.154. Epub 2015 Aug 24. No abstract available.

PMID:
26386930
23.

Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.

Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, Barbui C, Leucht S, Furukawa TA.

J Affect Disord. 2015 Jul 15;180:179-84. doi: 10.1016/j.jad.2015.03.021. Epub 2015 Mar 31.

24.

Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.

Del Favero S, Place J, Kropff J, Messori M, Keith-Hynes P, Visentin R, Monaro M, Galasso S, Boscari F, Toffanin C, Di Palma F, Lanzola G, Scarpellini S, Farret A, Kovatchev B, Avogaro A, Bruttomesso D, Magni L, DeVries JH, Cobelli C, Renard E; AP@home Consortium.

Diabetes Obes Metab. 2015 May;17(5):468-76. doi: 10.1111/dom.12440. Epub 2015 Feb 16.

PMID:
25600304
25.

Abnormalities in cortical gray matter density in borderline personality disorder.

Rossi R, Lanfredi M, Pievani M, Boccardi M, Rasser PE, Thompson PM, Cavedo E, Cotelli M, Rosini S, Beneduce R, Bignotti S, Magni LR, Rillosi L, Magnaldi S, Cobelli M, Rossi G, Frisoni GB.

Eur Psychiatry. 2015 Feb;30(2):221-7. doi: 10.1016/j.eurpsy.2014.11.009. Epub 2015 Jan 2.

26.

Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine.

Purgato M, Gastaldon C, Papola D, Magni LR, Rossi G, Barbui C.

Acta Psychiatr Scand. 2015 Jun;131(6):408-16. doi: 10.1111/acps.12381. Epub 2014 Dec 11. Review.

PMID:
25495269
27.

Designing an artificial pancreas architecture: the AP@home experience.

Lanzola G, Toffanin C, Di Palma F, Del Favero S, Magni L, Bellazzi R.

Med Biol Eng Comput. 2015 Dec;53(12):1271-83. doi: 10.1007/s11517-014-1231-1. Epub 2014 Nov 28.

PMID:
25430423
28.

Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.

Chase HP, Doyle FJ 3rd, Zisser H, Renard E, Nimri R, Cobelli C, Buckingham BA, Maahs DM, Anderson S, Magni L, Lum J, Calhoun P, Kollman C, Beck RW; Control to Range Study Group.

Diabetes Technol Ther. 2014 Oct;16(10):623-32. doi: 10.1089/dia.2014.0050. Epub 2014 Sep 4.

29.

Risk of perioperative seizures in patients undergoing craniotomy with intraoperative brain mapping.

Conte V, Carrabba G, Magni L, L'Acqua C, Magnoni S, Bello L, Colombo A, Stocchetti N.

Minerva Anestesiol. 2015 Apr;81(4):379-88. Epub 2014 Jul 24.

PMID:
25057931
30.

Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.

Zisser H, Renard E, Kovatchev B, Cobelli C, Avogaro A, Nimri R, Magni L, Buckingham BA, Chase HP, Doyle FJ 3rd, Lum J, Calhoun P, Kollman C, Dassau E, Farret A, Place J, Breton M, Anderson SM, Dalla Man C, Del Favero S, Bruttomesso D, Filippi A, Scotton R, Phillip M, Atlas E, Muller I, Miller S, Toffanin C, Raimondo DM, De Nicolao G, Beck RW; Control to Range Study Group.

Diabetes Technol Ther. 2014 Oct;16(10):613-22. doi: 10.1089/dia.2014.0066. Epub 2014 Jul 8. Erratum in: Diabetes Technol Ther. 2015 Jan;17(1):68. Vistenin, Roberto [corrected to Visentin, Roberto].

31.

Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.

Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Mize LB, Farret A, Place J, Bruttomesso D, Del Favero S, Boscari F, Galasso S, Avogaro A, Magni L, Di Palma F, Toffanin C, Messori M, Dassau E, Doyle FJ 3rd.

Diabetes Care. 2014 Jul;37(7):1789-96. doi: 10.2337/dc13-2076. Epub 2014 Jun 14.

32.

Monitoring Artificial Pancreas Trials Through Agent-based Technologies: A Case Report.

Lanzola G, Scarpellini S, Di Palma F, Toffanin C, Del Favero S, Magni L, Bellazzi R; on behalf of the AP@home consortium.

J Diabetes Sci Technol. 2014 Mar;8(2):216-224. Epub 2014 Mar 2.

33.

First use of model predictive control in outpatient wearable artificial pancreas.

Del Favero S, Bruttomesso D, Di Palma F, Lanzola G, Visentin R, Filippi A, Scotton R, Toffanin C, Messori M, Scarpellini S, Keith-Hynes P, Kovatchev BP, Devries JH, Renard E, Magni L, Avogaro A, Cobelli C; AP@home Consortium.

Diabetes Care. 2014;37(5):1212-5. doi: 10.2337/dc13-1631.

PMID:
24757228
34.

Myasthenia gravis and heart failure: is ivabradine a useful drug?

Venturini E, Pellegrinetti A, Marabotti C, Magni L, Testa R.

Int J Cardiol. 2014 Jun 1;174(1):e4-6. doi: 10.1016/j.ijcard.2014.03.202. Epub 2014 Apr 6. No abstract available.

PMID:
24746503
35.

Paroxetine versus other anti-depressive agents for depression.

Purgato M, Papola D, Gastaldon C, Trespidi C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2014 Apr 3;(4):CD006531. doi: 10.1002/14651858.CD006531.pub2. Review.

PMID:
24696195
36.

Fluoxetine versus other types of pharmacotherapy for depression.

Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2013 Jul 17;(7):CD004185. Review.

PMID:
24353997
37.

Artificial pancreas: model predictive control design from clinical experience.

Toffanin C, Messori M, Di Palma F, De Nicolao G, Cobelli C, Magni L.

J Diabetes Sci Technol. 2013 Nov 1;7(6):1470-83.

38.

Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management.

Luijf YM, DeVries JH, Zwinderman K, Leelarathna L, Nodale M, Caldwell K, Kumareswaran K, Elleri D, Allen JM, Wilinska ME, Evans ML, Hovorka R, Doll W, Ellmerer M, Mader JK, Renard E, Place J, Farret A, Cobelli C, Del Favero S, Dalla Man C, Avogaro A, Bruttomesso D, Filippi A, Scotton R, Magni L, Lanzola G, Di Palma F, Soru P, Toffanin C, De Nicolao G, Arnolds S, Benesch C, Heinemann L; AP@home Consortium.

Diabetes Care. 2013 Dec;36(12):3882-7. doi: 10.2337/dc12-1956. Epub 2013 Oct 29.

39.

Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement.

Grassi G, Seravalle G, Buzzi S, Magni L, Brambilla G, Quarti-Trevano F, Dell'Oro R, Mancia G.

J Hypertens. 2013 Jun;31(6):1131-5. doi: 10.1097/HJH.0b013e3283605c71.

PMID:
23552126
40.

In vitro effects of Beta-2 agonists on skeletal muscle differentiation, hypertrophy, and atrophy.

Wannenes F, Magni L, Bonini M, Dimauro I, Caporossi D, Moretti C, Bonini S.

World Allergy Organ J. 2012 Jun;5(6):66-72. doi: 10.1097/WOX.0b013e31825eff8b.

41.

Catheter-induced thrombosis of the superior vena cava.

Venturini E, Becuzzi L, Magni L.

Case Rep Vasc Med. 2012;2012:469619. doi: 10.1155/2012/469619. Epub 2012 Nov 6.

42.

Structural brain features of borderline personality and bipolar disorders.

Rossi R, Pievani M, Lorenzi M, Boccardi M, Beneduce R, Bignotti S, Borsci G, Cotelli M, Giannakopoulos P, Magni LR, Rillosi L, Rosini S, Rossi G, Frisoni GB.

Psychiatry Res. 2013 Aug 30;213(2):83-91. doi: 10.1016/j.pscychresns.2012.07.002. Epub 2012 Nov 10.

PMID:
23146251
43.

Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.

Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ 3rd, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B; International Artificial Pancreas Study Group.

Diabetes. 2012 Sep;61(9):2230-7. Epub 2012 Jun 11.

44.

Modular closed-loop control of diabetes.

Patek SD, Magni L, Dassau E, Karvetski C, Toffanin C, De Nicolao G, Del Favero S, Breton M, Man CD, Renard E, Zisser H, Doyle FJ 3rd, Cobelli C, Kovatchev BP; International Artificial Pancreas (iAP) Study Group.

IEEE Trans Biomed Eng. 2012 Nov;59(11):2986-99. doi: 10.1109/TBME.2012.2192930. Epub 2012 Apr 3.

45.

Bringing the artificial pancreas home: telemedicine aspects.

Lanzola G, Capozzi D, Serina N, Magni L, Bellazzi R.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1381-6. Review.

46.

Single coronary artery from the right sinus of Valsalva.

Venturini E, Magni L.

Heart Int. 2011;6(1):e5. doi: 10.4081/hi.2011.e5. Epub 2011 Jul 21.

47.

Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.

Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1374-81.

48.

Amoxicillin-induced Kounis syndrome manifesting as late stent thrombosis.

Venturini E, Magni L, Kounis NG.

Int J Cardiol. 2011 Aug 18;151(1):e26-8. doi: 10.1016/j.ijcard.2010.04.069. Epub 2010 May 14. No abstract available.

PMID:
20471121
49.

Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.

Magni L, Forgione M, Toffanin C, Dalla Man C, Kovatchev B, De Nicolao G, Cobelli C.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1091-8.

50.

Control to range for diabetes: functionality and modular architecture.

Kovatchev B, Patek S, Dassau E, Doyle FJ 3rd, Magni L, De Nicolao G, Cobelli C; Juvenile Diabetes Research Foundation Artificial Pancreas Consortium.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1058-65.

Supplemental Content

Support Center